28. September 2018
APGI Information Day, co-organized with EVONIK 27 November, 2018 CNAM, 292 rue Saint-Martin, 75003 Paris, France More information and registration here !
10. July 2018
Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. Global Biologic Excipients Market:...
15. August 2017
e-Lab is now onCare We redesigned the platform for you - so that it's easier to find what you're looking for and to simplify your daily work. onCare does not only have a new appearance, it also has new functionalities. A completely new design leverages an intuitive interface so that you can easily access the information you seek. Increased interaction enabling you to focus on the topics you are most interested in. A fully enhanced Coating Calculator can calculate the best oral drug delivery...
12. July 2017
Functional EUDRAGIT® polymers offer a wide variety of formulation options, which allow formulation design tailored to specific therapeutic requirements or the API characteristics. By combining different polymer types or applying several coating layers, almost every desired release profile can be achieved.
11. July 2017
Submit your publication on RESOMER® polymers now and win
the RESOMER® Award 2017!
12. March 2016
Evonik has developed a formulation technology, which offers a novel approach to developing alcohol resistant oral drug products with delayed or sustained release profiles. EUDRATEC™ ADD delivers a solution to the problem of alcohol-induced dose dumping of modified release dosage forms and enables the pharmaceutical industry to be in accordance with the sharpened requirements of the US-FDA. If patients take oral drugs, designed with a modified release (MR) profile, together with alcohol, the...
28. September 2015
Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says. More